ab120539 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab120539 は 4 報の論文で使用されています。

  • Rollema H  et al. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol 78:813-24 (2009). PubMed: 19501054
  • Rollema H  et al. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-94 (2007). PubMed: 17157884
  • Mihalak KB  et al. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-5 (2006). PubMed: 16766716
  • Ruchaud S  et al. Ethylene glycol ethers as hemopoietic toxins--in vitro studies of acute exposure. Leukemia 6:328-34 (1992). PubMed: 1588795

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"